Home | Welcome to Contract Pharma   
Last Updated Wednesday, April 23 2014
Print RSS Feed

Breaking News

Related Searches:
April 12, 2011
Pieris AG has entered into a collaboration and license agreement with Daiichi Sankyo Co. Ltd., under which Pieris will apply its Anticalin scaffold technology to discover novel Anticalins against two Daiichi Sankyo targets.   Read More »
April 12, 2011
Novartis AG is discontinuing development of Tasigna as a treatment for cancerous tumors of the gastrointestinal tract.  Read More »
April 12, 2011
NSF-DBA has added five pharmaceutical experts to provide consulting and in-house training services to help companies comply with international regulations and improve quality management systems.  Read More »
April 12, 2011
Orasi Medical has entered into an agreement with Biogen Idec to test novel biomarkers for the development of treatments for central nervous system (CNS) disorders.  Read More »
April 11, 2011
Roche and Lonza have entered into a distribution agreement for the commercialization of Roche’s MycoTOOL mycoplasma PCR assays.   Read More »
April 11, 2011
Ken Jones has been appointed president and chief executive officer of Astellas Pharma Europe Ltd. (APEL), the European subsidiary Astellas Pharma, Inc.  Read More »
April 11, 2011
Merck & Co. and Sun Pharmaceutical Industries have created a joint venture to develop, manufacture and commercialize new combinations and formulations of branded generics in emerging markets.  Read More »
April 11, 2011
Biogen Idec achieved positive results from DEFINE, a Phase III trial to evaluate the investigational oral compound BG-12 (dimethyl fumarate) as a monotherapy in people with relapsing-remitting multiple sclerosis (RRMS).  Read More »
April 11, 2011
Johnson & Johnson received approval from the FDA for Invega (paliperidone) extended-release tablets for the treatment of schizophrenia in adolescents 12 to 17 years of age.  Read More »
April 8, 2011
Eisai Inc. has established a subsidiary in Brazil called Eisai Participaš§es Ltda. (Eisai Brazil), which will be based in Sao Paulo.  Read More »
April 8, 2011
Amgen has expanded its operations into Brazil with the acquisition of Bergamo, a privately held Brazilian pharmaceutical company, for approximately $215 million.   Read More »
April 8, 2011
Impax Laboratories has entered into a collaboration with Banner Pharmacaps to supply and commercialize two undisclosed softgel capsule products.  Read More »
April 8, 2011
Pharma’s French manufacturing sites in Le Vaudreuil and Val-de-Reuil have been registered as contract test labs for extractables testing with the FDA.  Read More »
April 8, 2011
NextPharma has installed a ModuC LS IPC encapsulation/over-encapsulation filling machine at its Clinical Trials Services Center in G÷ttingen, Germany.   Read More »
April 7, 2011
Pfizer and Zacharon Pharmaceuticals have entered into a strategic research collaboration to develop drugs for orphan diseases, including lysosomal storage disorders.  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On